ALB and infection: Interestingly, although other studies have shown that SMAC mimetics selectively kill HIV-infected MDMs (10, 11), neither LCL-161 nor birinapant treatment of MDMs resulted in significant cell death in either bulk or individual HSA−/HSA+ populations in our infection model, emphasizing the importance of the HIV infection models used.